Introduction Semaglutide, a groundbreaking medication, has emerged as a transformative solution for managing type 2 diabetes, obesity, and overall metabolic health. A part of the GLP-1 receptor agonist class, Semaglutide mimics a natural hormone called glucagon-like peptide-1 (GLP-1), which regulates blood sugar, promotes insulin secretion, and suppresses appetite. Its dual https://dna-testing-services31964.wikilowdown.com/6492485/semaglutide_a_revolutionary_treatment_for_diabetes_obesity_and_cardiovascular_health